FDA Vaccine Advisory Committee Meeting Canceled

With no explanation, the FDA canceled the meeting of VRBPAC, scheduled to discuss the makeup of the 2025-2026 seasonal influenza vaccines, which could affect next year’s supply of influenza vaccine.